Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
| Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action |
| Autore | Allison Simon J |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (206 p.) |
| Soggetto topico |
History of engineering & technology
Technology: general issues |
| Soggetto non controllato |
5-FU resistance
8-hydroxydaidzein affibody drug conjugate (AffiDC) affibody molecule albumin binding domain angiogenesis anti-cancer agent anticancer drug apoptosis AQ4N autophagy B-lactam steroid alkylators BCR-ABL biomarker bioprecursor breast cancer BxPC-3 c-myc cancer hallmarks CCN1 colorectal cancer Connectivity Map CYP1A1 CYP1B1 CYP2W1 Cytochrome P450 DM1 drug repurposing duocarmycin EGFR tyrosine kinase inhibitor emtansine expression gene silencing Genomics of Drug Sensitivity in Cancer glioblastoma HepG2 Huh7 human epidermal growth factor receptor 3 (HER3) hybrid steroidal alkylating agents in vivo imaging invasion isatin sulfonamides K562 MAPK mesenchymal-amoeboid transition microtubule acetylation migration molecular docking n/a nanoparticles nanosystems NF-κB oncogene ovarian cancer phortress photon upconversion PLGA poly (ADP-ribose) polymerase inhibitors prodrug RNA interference siRNA synthetic lethality triple-negative breast cancer triplet-triplet annihilation |
| ISBN | 3-0365-5222-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Novel Anti-cancer Agents and Cellular Targets and Their Mechanism |
| Record Nr. | UNINA-9910619465503321 |
Allison Simon J
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Oncogenic RAS-dependent Reprogramming of Cellular Plasticity
| Oncogenic RAS-dependent Reprogramming of Cellular Plasticity |
| Autore | Rimessi Alessandro |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 online resource (127 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
cancer hallmarks
cellular plasticity oncogenesis oncogenic Ras therapy resistance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557414403321 |
|
Rimessi Alessandro
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||